Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease

Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3374-8. doi: 10.1002/anie.201209885. Epub 2013 Feb 10.
No abstract available

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Amyloid / antagonists & inhibitors
  • Amyloid / metabolism*
  • Amyloid beta-Peptides / antagonists & inhibitors
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Brain / metabolism
  • Cell Survival / drug effects
  • Coordination Complexes / chemistry*
  • Coordination Complexes / therapeutic use
  • Coordination Complexes / toxicity
  • Disease Models, Animal
  • Mice
  • Mice, Transgenic
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / metabolism
  • Platinum / chemistry*
  • Quinolines / chemistry
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • Coordination Complexes
  • Peptide Fragments
  • Quinolines
  • amyloid beta-protein (1-42)
  • Platinum